Martine C Maculaitis

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Ejection Fraction

Small Cell Lung Cancer

Top Venues

Future oncology (London, England)

International journal of clinical practice

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Kathleen M Beusterien, Amy W Law, Martine C Maculaitis, Oliver Will, Lewis Kopenhafer, Patrick Olsen, A Brett Hauber, Jeffrey T Vietri, Joseph C Cappelleri, Joshua R Coulter, Kimberly M Shea
Healthcare Providers' and Pregnant People's Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial Virus. Vaccines 12 (5) (2024)
Kathleen M Beusterien, Amy W Law, Martine C Maculaitis, Oliver Will, Lewis Kopenhafer, Patrick Olsen, A Brett Hauber, Jeffrey T Vietri, Joseph C Cappelleri, Joshua R Coulter, Kimberly M Shea
Healthcare Providers' and Pregnant People's Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial Virus. Vaccines 12 (5) (2024)
Suvina Amin, Sara M Tolaney, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Emily Mulvihill, Reshma Shinde, Kimmie McLaurin
Benefit-risk trade-offs in treatment choice in advanced HER2 negative breast cancer: patient and oncologist perspectives. Future oncology (London, England) 18 (16) (2022)
Candice Yong, M Janelle Cambron-Mellott, Brian Seal, Oliver Will, Martine C Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla, Ranee Mehra
Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment. Patient preference and adherence 16 (2022)
Ahmed Shelbaya, John M Kelton, Jeffrey Thompson, Jose Mj Alvir, Martine C Maculaitis, Jingyan Yang
Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA. Future oncology (London, England) 17 (30) (2021)
Rebecca L Stone, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Stephanie Ritz, Emily Mulvihill, Matthew Monberg, Elizabeth A Szamreta, Suvina Amin, Kimmie McLaurin
Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer. Future oncology (London, England) (2021)
Lauren J Lee, Terence A Maguire, Martine C Maculaitis, Birol Emir, Vicky W Li, Mara Jeffress, Jim Z Li, Kelly H Zou, Shaantanu S Donde, David Taylor
Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real-world observational study in the United Kingdom. International journal of clinical practice 75 (4) (2020)